GAITHERSBURG, Md. and SHANGHAI, June 23, 2022 /PRNewswire/ — I-Mab (“I-Mab” or the “Firm”) (Nasdaq: IMAB), a clinical-stage biopharmaceutical firm dedicated to the invention, improvement, and commercialization of novel biologics, at this time introduced that it was ranked among the many high firms in 5 totally different classes […]
Sunday, Aug 14, 2022
Breaking News